TransMedics Group Inc. (纳斯达克股票代码:TMDX)盘后股价大涨9.57%,主要受到公司刚刚公布的第四季度业绩表现优异的利好消息影响。
根据公司财报显示,TransMedics Group第四季度每股收益为0.19美元,高于分析师预期的0.16美元。公司同时也录得1.216亿美元的季度销售额,超越预期的1.103亿美元。相比去年同期,公司每股收益和销售额分别增长了58.33%和49.83%。
业绩好于市场预期,显示出公司业务的强劲增长。分析人士预计,这一出色业绩或将帮助公司提振投资者信心,扩大公司在器官运输和生命科学领域的市场份额,从而保持良好发展势头。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.